RazorSharpDNA 🧬 (@RazorSharpDNA) header
RazorSharpDNA 🧬 (@RazorSharpDNA) profile picture

Biotech, explained by the science 🧬 Gene editing, readouts, M&A, AI firsts, longevity, psychedelics. Primary sources, honest caveats. Not 💵 advice.

Joined November 2011
Photo by RazorSharpDNA 🧬 (@RazorSharpDNA)Photo by RazorSharpDNA 🧬 (@RazorSharpDNA)Photo by RazorSharpDNA 🧬 (@RazorSharpDNA)Photo by RazorSharpDNA 🧬 (@RazorSharpDNA)Photo by RazorSharpDNA 🧬 (@RazorSharpDNA)Photo by RazorSharpDNA 🧬 (@RazorSharpDNA)Photo by RazorSharpDNA 🧬 (@RazorSharpDNA)Photo by RazorSharpDNA 🧬 (@RazorSharpDNA)Photo by RazorSharpDNA 🧬 (@RazorSharpDNA)Photo by RazorSharpDNA 🧬 (@RazorSharpDNA)
RazorSharpDNA 🧬 retweeted
11
96
1
920
17,949
RazorSharpDNA 🧬 retweeted
You don't need experience to start, you gain experience by starting.
590
1,868
238
14,657
470,177
RazorSharpDNA 🧬 retweeted
18
286
10
2,495
39,354
RazorSharpDNA 🧬 retweeted
“Action produces information. Just keep doing stuff.” — Brian Armstrong
11
238
13
2,038
50,043
RazorSharpDNA 🧬 retweeted
230
3,147
176
27,282
617,871
RazorSharpDNA 🧬 retweeted
The bottom is in.
View from THE bottom? Over 100 trading days through November 5th $XLK underperformed $SPY by -12.7 pts, the most since at least 2010. When Tech has lagged the S&P by 2 standard deviations in the past, the downside has been limited, often marking the bottom. $ES_F $SPX $MSFT $MU $AVGO $QQQ $NDX $SPCX $AAPL $NVDA $MAGS $SMH
8
8
125
11,599
RazorSharpDNA 🧬 retweeted
JUST IN: Elon Musk says agentic demand is "growing faster" than he has ever seen anything grow
75
118
30
2,042
92,419
RazorSharpDNA 🧬 retweeted
People who cured / are curing their own cancer on X: 1/ @sytses - bone cancer, billionaire founder of Gitlab, developed 10+ personalized therapies for himself. 2/ @paul_conyngham - shrank his dog Rosie's mast cell cancer tumors after chemo and surgery weren't enough. Now backed by YC and Founders Fund 3/ @miriamgonp - stage 4 breast cancer, tumor sequenced, searching for vaccine manufacturer now 4/ @kevinace - stage 4 lung cancer, angel investor in 300+ companies, first drug stopped working after 18 months. Vaccine designed, now paying $300k out of pocket for the vaccine 5/ @masonbgrant: going founder mode on his his 32-year-old wife's rare liver cancer, sequencing her tumor with AI agents 6/ @ArunRLverma: former product leader at Atoms and Shopify, brain tumor, built a vaccine from his tumor. Now building an AI health agent startup based on what he went through We're going to make it
109
637
120
4,895
464,208
RazorSharpDNA 🧬 retweeted
Do the work. Show the work. Teach the work. Sell the system. Secret to winning.
160
278
17
2,783
47,186
RazorSharpDNA 🧬 retweeted
3
148
7
764
17,925
RazorSharpDNA 🧬 retweeted
💀💀
20
126
15
1,716
162,733
RazorSharpDNA 🧬 retweeted
"All benefits in life come from compound interest, whether in money, relationships, love, health, activities, or habits." — Naval Ravikant
2
65
3
472
9,498
RazorSharpDNA 🧬 retweeted
Pengu spotted in Seoul 🇰🇷
60
102
13
802
60,025
RazorSharpDNA 🧬 retweeted
uptober🟩
245
406
70
5,199
168,583
RazorSharpDNA 🧬 retweeted
My richest mentor told me: "By the time most people are done analyzing, I've already made 3 mistakes and found a better way." Being slow costs more than being wrong.
199
1,654
63
12,487
186,089
RazorSharpDNA 🧬 retweeted
What most people don’t understand about passive income is the amount of active hard work that goes into creating it in the first place.
59
63
9
652
48,056
RazorSharpDNA 🧬 retweeted
Soon...
7,094
6,563
4,786
58,507
11,871,290
RazorSharpDNA 🧬 retweeted
You are not a Jack of all trades. You have ADHD.
665
3,190
1,181
24,121
965,428
RazorSharpDNA 🧬 retweeted
🚨WOW! According to @BLaw $BEAM has recently filed a lawsuit against one of its former scientists which is the co-founder of the Chinese BioTech company YolTech Therapeutics now merged into $BOLD via Serapha Bio, claiming that its former employee stole its trade secrets. According to BEAM’s lawsuit while the employee was allegedly still on the company’s payroll the employee used stolen trade secrets to rapidly file patents on a treatment for the same rare lung and liver disease - alpha-1 antitrypsin deficiency or AATD, for which Beam has started developing its own Base-Editing treatment called BEAM-302 almost a decade ago. When I read last June that YolTech was merging into $BOLD - via the Boundless - Serapha merger, I immediately wrote that “the fact that an American technology - Base Editing - which was invented and developed in the U.S by Prof. @davidrliu of Harvard and the @broadinstitute, was taken to China to be used in order to develop a parallel pipeline to BEAM’s (AATD) and then returned to the American stock market via a back channel merger is a super negative signal for the entire American BioTech and Pharma ecosystem.” BEAM practically had no other choice but to sue its former employe and this will be a super important test case for the entire American BioTech and Pharma ecosystem and to its ability to safeguard its IP rights. Super interesting!
Intellectual Property (IP) disputes have been part of the CRISPR and Gene Editing landscape from its very beginning. Although previous disputes were mostly between American companies 🧵👇 the $BEAM - $BOLD one is IMO fundamentally different. The fact that an American technology - Base Editing - which was invented and developed in the U.S by Prof. @davidrliu of Harvard and the @broadinstitute, was taken to China to be used in order to develop a parallel pipeline to BEAM’s (AATD) and then returned to the American stock market via a back channel merger is a super negative signal for the entire American BioTech & Pharma ecosystem. IMO this precedent literally means that anyone can simply take a proprietary technology which was developed in the U.S, copy it entirely - for the lack of a better term, only to profit from it without rewarding the actual scientists and entrepreneurs who have spent their lives developing these groundbreaking technologies and bringing them into the clinic. American policy makers need to ask themselves what kind of an incentive a case such as this provides for the next “David Liu” who is sitting right now in his or her lab somewhere in America and for hours upon hours is developing the next novel Genetic delivery platform or the next cure for Cancer? This will have serious implications on the entire industry - far beyond these two companies!
5
13
4
58
29,823
RazorSharpDNA 🧬 retweeted
The wealth gap between people using AI and those ignoring it is going to be massive. I’m doing things in one hour that used to take me five days. It’s like watching someone use a horse and buggy while everyone else has a car. There’s no competition. Adapt or get left behind.
46
16
2
338
23,112